Publications by authors named "N G Sauer"

Xenoestrogens (XEs) are a group of exogenous substances that may interfere with the functioning of the endocrine system. They may mimic the function of estrogens, and their sources are plants, water or dust, plastic, chemical agents, and some drugs. Thus, people are highly exposed to their actions.

View Article and Find Full Text PDF
Article Synopsis
  • Avelumab is an antibody that targets PD-L1 in cancer cells, focusing on its effects on two potential cancer targets, CD15 and IL-17RA, which are influenced by the STAT3 protein.
  • The study aimed to see if treating renal cancer cells with avelumab affects CD15 and IL-17RA expression and how STAT3 mediates this regulation.
  • Results showed that avelumab treatment reduced STAT3 levels, increased CD15 expression in certain cancer cells, and altered IL-17RA levels only in healthy cells, highlighting the complex role these proteins play in cancer therapy.
View Article and Find Full Text PDF

Background: Basal Cell Carcinoma (BCC) is the most common form of skin cancer, characterized by its low metastatic potential yet considerable diversity in clinical and dermatoscopic presentation. Advances in dermatoscopy have significantly improved the early detection of BCC, revealing specific patterns that guide diagnosis and management. Parallelly, immunohistochemical markers have been explored for their potential to elucidate the underlying tumor biology and prognosis, with particular focus on angiogenesis, melanocytic activity, and lymphangiogenesis.

View Article and Find Full Text PDF

Managing advanced basal cell carcinoma (BCC) in patients with Gorlin-Goltz syndrome presents unique clinical challenges due to the tumor's aggressive nature and potential for widespread metastasis. This case study details a sequential treatment regimen for a 68-year-old female patient with an extensive, inoperable BCC. Employing a multimodal approach that integrates radiotherapy, the Hedgehog pathway inhibitor vismodegib, and High-Intensity Focused Ultrasound (HIFU), we demonstrate the potential for nearly complete remission in a patient with advanced BCC.

View Article and Find Full Text PDF

The rising incidence of Basal Cell Carcinoma (BCC), especially among individuals with significant sun exposure, underscores the need for effective and minimally invasive treatment alternatives. Traditional surgical approaches, while effective, often result in notable cosmetic and functional limitations, particularly for lesions located on the face. This study explores High-Intensity Focused Ultrasound (HIFU) as a promising, non-invasive treatment option that aims to overcome these challenges, potentially revolutionizing BCC treatment by offering a balance between efficacy and cosmetic outcomes.

View Article and Find Full Text PDF